163 related articles for article (PubMed ID: 1409423)
1. The role of oncogenes and growth factors in progressive melanoma-genesis.
Albino AP
Pigment Cell Res; 1992; Suppl 2():199-218. PubMed ID: 1409423
[No Abstract] [Full Text] [Related]
2. The human melanocyte system as a model for studies on tumor progression.
Valyi-Nagy I; Rodeck U; Kath R; Mancianti ML; Clark WH; Herlyn M
Basic Life Sci; 1991; 57():315-26; discussion 326-8. PubMed ID: 1814292
[No Abstract] [Full Text] [Related]
3. Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions.
Papp T; Jafari M; Schiffmann D
J Cancer Res Clin Oncol; 1996; 122(9):541-8. PubMed ID: 8781568
[TBL] [Abstract][Full Text] [Related]
4. Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study.
Loir B; Pérez Sánchez C; Ghanem G; Lozano JA; García-Borrón JC; Jiménez-Cervantes C
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1083-92. PubMed ID: 10644013
[TBL] [Abstract][Full Text] [Related]
5. Lack of evidence of Ki-ras codon 12 mutations in melanocytic lesions.
Albino AP; Nanus DM; Davis ML; McNutt NS
J Cutan Pathol; 1991 Aug; 18(4):273-8. PubMed ID: 1939786
[TBL] [Abstract][Full Text] [Related]
6. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
[TBL] [Abstract][Full Text] [Related]
7. MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression.
Wang D; Yang W; Du J; Devalaraja MN; Liang P; Matsumoto K; Tsubakimoto K; Endo T; Richmond A
Oncogene; 2000 Sep; 19(40):4647-59. PubMed ID: 11030154
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
9. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
10. Antigens associated with tumor progression in melanocytic neoplasia.
Elder DE; Herlyn M
Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
[No Abstract] [Full Text] [Related]
11. Aberrant DNA methylation silences the novel heat shock protein H11 in melanoma but not benign melanocytic lesions.
Sharma BK; Smith CC; Laing JM; Rucker DA; Burnett JW; Aurelian L
Dermatology; 2006; 213(3):192-9. PubMed ID: 17033167
[TBL] [Abstract][Full Text] [Related]
12. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
13. Protein patterns of benign and malignant human melanocytes show consistent changes in gene expression.
Eberle J; Garbe C; Kroumpouzos G; Orfanos CE
Recent Results Cancer Res; 1995; 139():123-35. PubMed ID: 7597285
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
[TBL] [Abstract][Full Text] [Related]
15. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
[TBL] [Abstract][Full Text] [Related]
16. Production of cytokines by human melanoma cells and melanocytes.
Krüger-Krasagakes S; Krasagakis K; Garbe C; Diamantstein T
Recent Results Cancer Res; 1995; 139():155-68. PubMed ID: 7597287
[TBL] [Abstract][Full Text] [Related]
17. Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
Williams EA; Shah N; Danziger N; Montesion M; Sokol ES; Pavlick DC; Miller VA; Ross JS; Elvin JA; Tse JY
J Am Acad Dermatol; 2021 Apr; 84(4):1069-1071. PubMed ID: 32682887
[No Abstract] [Full Text] [Related]
18. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin.
Reichrath J; Seyfried P; Braun R; Müller SM; Baum HP; Bahmer FA
Dermatology; 1997; 194(2):136-9. PubMed ID: 9094461
[TBL] [Abstract][Full Text] [Related]
19. p53 expression is rare in cutaneous melanomas.
Saenz-Santamaría MC; McNutt NS; Bogdany JK; Shea CR
Am J Dermatopathol; 1995 Aug; 17(4):344-9. PubMed ID: 8600797
[TBL] [Abstract][Full Text] [Related]
20. [Dysplastic nevus syndrome].
Kint A
Z Hautkr; 1986 May; 61(9):595-8. PubMed ID: 3716535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
